Wall Street Journal Examines Challenges Drug Industry Will Face In Coming Years

Well worth the read, using business intelligence the pharmaceutical industry will be able to predict issues and adjust marketing and other issues as needed..the pharma industry uses business intelligence far more than many health care related businesses...so they will be prepared when the time comes to hit the wall..BD

Over the next few years, the pharmaceutical industry will hit a wall," the Wall Street Journal reports in an examination of challenges that face large pharmaceutical companies. In future years, some of the "top-selling drugs in industry history will become history as patent protections expire," with generic competition "expected to wipe $67 billion from top companies' annual U.S. sales between 2007 and 2012" -- an amount equal to "roughly half of the companies' combined 2007 U.S. sales," according to the Journal.

" A number of pharmaceutical companies also have entered research initiatives or partnerships to develop biotechnology medications and have expanded their generic medication businesses. Some pharmaceutical companies also have indicated they will seek to outsource manufacturing capabilities to help reduce costs.